These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 31027376)
1. Mortalin (GRP75/HSPA9) Promotes Survival and Proliferation of Thyroid Carcinoma Cells. Starenki D; Sosonkina N; Hong SK; Lloyd RV; Park JI Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31027376 [TBL] [Abstract][Full Text] [Related]
2. Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells. Starenki D; Hong SK; Lloyd RV; Park JI Oncogene; 2015 Aug; 34(35):4624-34. PubMed ID: 25435367 [TBL] [Abstract][Full Text] [Related]
3. A mortalin/HSPA9-mediated switch in tumor-suppressive signaling of Raf/MEK/extracellular signal-regulated kinase. Wu PK; Hong SK; Veeranki S; Karkhanis M; Starenki D; Plaza JA; Park JI Mol Cell Biol; 2013 Oct; 33(20):4051-67. PubMed ID: 23959801 [TBL] [Abstract][Full Text] [Related]
4. Mitochondria-targeted nitroxide, Mito-CP, suppresses medullary thyroid carcinoma cell survival in vitro and in vivo. Starenki D; Park JI J Clin Endocrinol Metab; 2013 Apr; 98(4):1529-40. PubMed ID: 23509102 [TBL] [Abstract][Full Text] [Related]
5. Mortalin/HSPA9 targeting selectively induces KRAS tumor cell death by perturbing mitochondrial membrane permeability. Wu PK; Hong SK; Starenki D; Oshima K; Shao H; Gestwicki JE; Tsai S; Park JI Oncogene; 2020 May; 39(21):4257-4270. PubMed ID: 32291414 [TBL] [Abstract][Full Text] [Related]
6. Estrogen-related receptor alpha promotes thyroid tumor cell survival via a tumor subtype-specific regulation of target gene networks. Chen W; Song YS; Lee HS; Lin CW; Lee J; Kang YE; Kim SK; Kim SY; Park YJ; Park JI Oncogene; 2024 Jul; 43(31):2431-2446. PubMed ID: 38937602 [TBL] [Abstract][Full Text] [Related]
7. Mortalin (HSPA9) facilitates Wu PK; Hong SK; Chen W; Becker AE; Gundry RL; Lin CW; Shao H; Gestwicki JE; Park JI Sci Signal; 2020 Mar; 13(622):. PubMed ID: 32156782 [TBL] [Abstract][Full Text] [Related]
8. Analogs of the Heat Shock Protein 70 Inhibitor MKT-077 Suppress Medullary Thyroid Carcinoma Cells. Hong SK; Starenki D; Johnson OT; Gestwicki JE; Park JI Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162987 [TBL] [Abstract][Full Text] [Related]
9. Steady-State Levels of Phosphorylated Mitogen-Activated Protein Kinase Kinase 1/2 Determined by Mortalin/HSPA9 and Protein Phosphatase 1 Alpha in Wu PK; Hong SK; Park JI Mol Cell Biol; 2017 Sep; 37(18):. PubMed ID: 28674184 [TBL] [Abstract][Full Text] [Related]
10. Berberine could inhibit thyroid carcinoma cells by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest and suppressing migration via PI3K-AKT and MAPK signaling pathways. Li L; Wang X; Sharvan R; Gao J; Qu S Biomed Pharmacother; 2017 Nov; 95():1225-1231. PubMed ID: 28931215 [TBL] [Abstract][Full Text] [Related]
11. Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells. Starenki D; Hong SK; Wu PK; Park JI Cancer Biol Ther; 2017 Jul; 18(7):473-483. PubMed ID: 28475408 [TBL] [Abstract][Full Text] [Related]
12. Restoration of p53 functions by suppression of mortalin-p53 sequestration: an emerging target in cancer therapy. Shankaranarayana AH; Meduri B; Pujar GV; Hariharapura RC; Sethu AK; Singh M; Bidye D Future Med Chem; 2023 Nov; 15(22):2087-2112. PubMed ID: 37877348 [TBL] [Abstract][Full Text] [Related]
13. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition. Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619 [TBL] [Abstract][Full Text] [Related]
14. Mortalin - a multipotent chaperone regulating cellular processes ranging from viral infection to neurodegeneration. Flachbartová Z; Kovacech B Acta Virol; 2013; 57(1):3-15. PubMed ID: 23530819 [TBL] [Abstract][Full Text] [Related]
15. Sp1 regulates Raf/MEK/ERK-induced p21(CIP1) transcription in TP53-mutated cancer cells. Karkhanis M; Park JI Cell Signal; 2015 Mar; 27(3):479-86. PubMed ID: 25595558 [TBL] [Abstract][Full Text] [Related]
16. TP53 status regulates ACSL5-induced expression of mitochondrial mortalin in enterocytes and colorectal adenocarcinomas. Klaus C; Kaemmerer E; Reinartz A; Schneider U; Plum P; Jeon MK; Hose J; Hartmann F; Schnölzer M; Wagner N; Kopitz J; Gassler N Cell Tissue Res; 2014 Jul; 357(1):267-78. PubMed ID: 24770931 [TBL] [Abstract][Full Text] [Related]
17. The TUSC2 Tumour Suppressor Inhibits the Malignant Phenotype of Human Thyroid Cancer Cells via SMAC/DIABLO Protein. Mariniello RM; Orlandella FM; Stefano AE; Iervolino PLC; Smaldone G; Luciano N; Cervone N; Munciguerra F; Esposito S; Mirabelli P; Salvatore G Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973107 [TBL] [Abstract][Full Text] [Related]
19. The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast. Jin H; Ji M; Chen L; Liu Q; Che S; Xu M; Lin Z J Exp Clin Cancer Res; 2016 Mar; 35():42. PubMed ID: 26955804 [TBL] [Abstract][Full Text] [Related]
20. Mortalin peptides exert antitumor activities and act as adjuvants to antibody-mediated complement-dependent cytotoxicity. Jubran R; Saar-Ray M; Wawruszak A; Ziporen L; Donin N; Bairey O; Fishelson Z Int J Oncol; 2020 Oct; 57(4):1013-1026. PubMed ID: 32700755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]